REFILE-Japan's Takeda committed to single-digit U.S. drug price rises

TOKYO, Feb 1 (Reuters) - Japan's largest drugmaker, Takeda

Pharmaceuticals Co, on Wednesday said it would maintain

its pricing model in the U.S. market, brushing off demands by

U.S. President Donald...

Read more